| Motif ID |
Motif Logo |
Scanned Score Distribution |
Frequency of Motif |
Replicability Score |
Evolutionary Conservation Score |
Gene Targets |
Gene Ontology of CpGMM targets |
| CG_hsf1_promoter_p_PM_12_23_3 |
 |
 |
2 |
0.5 |
4.32E-05 |
PPARGC1B |
positive regulation of alkaline phosphatase activity [BP] |
| CG_hsf1_promoter_p_PM_12_13_3 |
 |
 |
1 |
0.25 |
1.80E-04 |
PCDHGB7,
PCDHGA12,
PCDHGB5,
PCDHGB4,
PCDHGA6,
CIDEA,
MLH1 |
intrinsic apoptotic signaling pathway in response to DNA damage [BP],
cell adhesion [BP],
homophilic cell adhesion [BP],
spindle midzone assembly involved in meiosis [BP],
meiotic metaphase I plate congression [BP],
calcium ion binding [MF] |
| CG_hsf1_promoter_p_PM_14_6_1 |
 |
 |
2 |
0.5 |
1.58E-05 |
CYP1A2 |
oxidative deethylation [BP],
toxin biosynthetic process [BP] |
| CG_hsf1_promoter_p_PM_12_25_2 |
 |
 |
2 |
0.5 |
2.00E-05 |
MYO3B,
HS3ST3B1,
KSR1 |
[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity [MF],
protein serine/threonine kinase activity [MF] |
| CG_hsf1_promoter_p_PM_14_13_2 |
 |
 |
1 |
0.25 |
3.66E-04 |
PCDHA7,
PCDHA4,
PCDHA5,
PCDHA9,
PCDHGA12,
PCDHGA8,
PCDHGB6,
PCDHA10,
PCDHA13,
PCDHGA7,
PCDHA6 |
integral to membrane [CC],
plasma membrane [CC],
cell adhesion [BP],
homophilic cell adhesion [BP],
calcium ion binding [MF],
integral to plasma membrane [CC] |
| CG_hsf1_promoter_p_PM_12_12_4 |
 |
 |
2 |
0.5 |
3.27E-04 |
D2HGDH,
PCDHGA11,
PCDHGA12,
PCDHGB7,
UTS2R,
PCDHGA6,
SDHAF2 |
homophilic cell adhesion [BP],
protein-FAD linkage [BP],
(R)-2-hydroxyglutarate dehydrogenase activity [MF],
urotensin II receptor activity [MF] |
| CG_hsf1_promoter_p_PM_14_16_1 |
 |
 |
1 |
0.25 |
2.67E-05 |
GMPR,
SLC22A1 |
norepinephrine transmembrane transporter activity [MF],
secondary active organic cation transmembrane transporter activity [MF],
acetylcholine transmembrane transporter activity [MF],
establishment or maintenance of transmembrane electrochemical gradient [BP],
dopamine transmembrane transporter activity [MF],
GMP reductase activity [MF] |
| CG_hsf1_promoter_p_PM_14_4_3 |
 |
 |
2 |
0.5 |
3.59E-05 |
NLRP6,
GNAS,
AVPR2 |
activation of adenylate cyclase activity [BP],
vasopressin receptor activity [MF] |
| CG_hsf1_promoter_p_PM_16_17_1 |
 |
 |
1 |
0.25 |
3.90E-05 |
GTPBP4 |
negative regulation of collagen binding [BP] |
| CG_hsf1_promoter_p_PM_12_10_2 |
 |
 |
2 |
0.5 |
3.85E-04 |
CAPN3 |
autolysis [BP],
G1 to G0 transition involved in cell differentiation [BP] |
| CG_hsf1_promoter_p_PM_12_1_3 |
 |
 |
1 |
0.25 |
3.08E-04 |
CA7,
SHMT2,
LTB4R |
leukotriene B4 receptor activity [MF],
one-carbon metabolic process [BP] |
| CG_hsf1_promoter_p_PM_12_6_3 |
 |
 |
1 |
0.25 |
1.28E-04 |
MPV17L |
negative regulation of hydrogen peroxide biosynthetic process [BP] |
| CG_hsf1_promoter_p_PM_12_18_2 |
 |
 |
2 |
0.5 |
4.45E-04 |
HNF1A |
renal glucose absorption [BP],
response to glucose stimulus [BP] |
| CG_hsf1_promoter_p_PM_14_5_2 |
 |
 |
3 |
0.75 |
1.43E-05 |
COL13A1,
IL4R,
UBC,
MAEA |
collagen type XIII [CC],
cytokine-mediated signaling pathway [BP],
hypothalamus gonadotrophin-releasing hormone neuron development [BP],
ubiquitin homeostasis [BP],
enucleate erythrocyte development [BP],
interleukin-4 receptor activity [MF] |
| CG_hsf1_promoter_p_PM_14_15_1 |
 |
 |
1 |
0.25 |
3.03E-05 |
FAM206A,
PANK2 |
glycine cleavage complex [CC],
pantothenate kinase activity [MF] |
| CG_hsf1_promoter_p_PM_14_11_2 |
 |
 |
3 |
0.5 |
3.83E-05 |
PCSK9 |
negative regulation of receptor recycling [BP],
very-low-density lipoprotein particle binding [MF] |
| CG_hsf1_promoter_p_PM_14_14_1 |
 |
 |
1 |
0.25 |
7.10E-05 |
KLHL17,
PIGQ |
phosphatidylinositol N-acetylglucosaminyltransferase activity [MF],
glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [CC],
POZ domain binding [MF] |
| CG_hsf1_promoter_p_PM_14_9_2 |
 |
 |
1 |
0.25 |
5.42E-05 |
STUB1,
BIRC7 |
positive regulation of chaperone-mediated protein complex assembly [BP],
regulation of natural killer cell apoptotic process [BP] |
| CG_hsf1_promoter_p_PM_14_10_3 |
 |
 |
3 |
0.5 |
9.24E-05 |
USB1 |
U6 snRNA 3'-end processing [BP] |
| CG_hsf1_promoter_p_PM_14_2_2 |
 |
 |
2 |
0.5 |
3.83E-04 |
PCDHA5,
PCDHGA11,
PCDHGA12,
PCDHGB7,
PCDHGB4,
PCDHA10,
PCDHA11,
PCDHA12,
PCDHA13,
PCDHA6 |
integral to membrane [CC],
plasma membrane [CC],
cell adhesion [BP],
homophilic cell adhesion [BP],
membrane [CC],
calcium ion binding [MF] |
| CG_hsf1_promoter_p_PM_16_15_1 |
 |
 |
1 |
0.25 |
6.01E-04 |
PCDHB14,
PCDHB6,
PCDHB15,
PCDHB4,
PCDHB8 |
synaptic transmission [BP],
cell adhesion [BP],
homophilic cell adhesion [BP],
calcium ion binding [MF],
calcium-dependent cell-cell adhesion [BP],
synapse assembly [BP],
nervous system development [BP] |
| CG_hsf1_promoter_p_PM_12_5_4 |
 |
 |
1 |
0.25 |
1.54E-04 |
PCDHA4,
PCDHA9,
EGFL7,
PCDHA11,
PCDHA12,
DPEP1,
DOLPP1 |
homophilic cell adhesion [BP],
dolichyldiphosphatase activity [MF],
cellular lactam catabolic process [BP],
calcium ion binding [MF] |
| CG_hsf1_promoter_p_PM_12_28_2 |
 |
 |
1 |
0.25 |
4.07E-05 |
CX3CL1 |
positive regulation of calcium-independent cell-cell adhesion [BP],
leukocyte adhesive activation [BP] |
| CG_hsf1_promoter_p_PM_16_14_2 |
 |
 |
1 |
0.25 |
5.94E-05 |
AIP,
GSTO1 |
glutathione dehydrogenase (ascorbate) activity [MF],
GAF domain binding [MF],
negative regulation of cyclic-nucleotide phosphodiesterase activity [BP],
methylarsonate reductase activity [MF],
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion [BP] |
| CG_hsf1_promoter_p_PM_12_26_2 |
 |
 |
2 |
0.5 |
3.58E-04 |
PCDHGA12,
PCDHGA11,
PCDHGB7,
PCDHGB5,
PCDHGA6,
FUK,
SIVA1 |
homophilic cell adhesion [BP],
CD27 receptor binding [MF],
fucokinase activity [MF],
calcium ion binding [MF] |
| CG_hsf1_promoter_p_PM_14_12_2 |
 |
 |
1 |
0.25 |
2.41E-06 |
AGXT |
glyoxylate catabolic process [BP],
oxalic acid secretion [BP],
L-alanine catabolic process [BP],
glycine biosynthetic process, by transamination of glyoxylate [BP],
serine-pyruvate transaminase activity [MF],
glyoxylate metabolic process [BP],
pyruvate biosynthetic process [BP],
L-cysteine catabolic process [BP],
alanine-glyoxylate transaminase activity [MF] |
| CG_hsf1_promoter_p_PM_16_5_2 |
 |
 |
2 |
0.5 |
6.68E-04 |
PCDHGA12,
PCDHB4,
PCDHB11,
PCDHGB7,
PCDHGB5,
PCDHGA11,
PCDHGA6,
PCDHB6 |
integral to membrane [CC],
plasma membrane [CC],
cell adhesion [BP],
homophilic cell adhesion [BP],
calcium ion binding [MF],
calcium-dependent cell-cell adhesion [BP],
synapse assembly [BP] |
| CG_hsf1_promoter_p_PM_12_19_4 |
 |
 |
3 |
0.75 |
1.51E-04 |
TFAP2B,
PPP2R1A |
peptidyl-serine dephosphorylation [BP],
cellular urea homeostasis [BP],
cellular creatinine homeostasis [BP],
cellular ammonia homeostasis [BP] |
| CG_hsf1_promoter_p_PM_16_2_2 |
 |
 |
1 |
0.25 |
1.45E-05 |
PIGQ |
phosphatidylinositol N-acetylglucosaminyltransferase activity [MF],
glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex [CC] |
| CG_hsf1_promoter_p_PM_12_30_4 |
 |
 |
3 |
0.75 |
1.10E-05 |
DBH,
AP1AR,
BLOC1S3,
STUB1 |
positive regulation of chaperone-mediated protein complex assembly [BP],
homoiothermy [BP],
chromaffin granule lumen [CC],
transport vesicle [CC],
dopamine beta-monooxygenase activity [MF],
regulation of Arp2/3 complex-mediated actin nucleation [BP] |
| CG_hsf1_promoter_p_PM_16_3_2 |
 |
 |
2 |
0.5 |
3.89E-04 |
PCDHA13,
PCDHA9,
PCDHA12 |
homophilic cell adhesion [BP] |
| CG_hsf1_promoter_p_PM_12_15_3 |
 |
 |
1 |
0.25 |
1.99E-04 |
MERTK,
ZNF205 |
positive regulation of hydrogen peroxide biosynthetic process [BP],
negative regulation of lymphocyte activation [BP],
rhabdomere [CC],
positive regulation of mitochondrial outer membrane permeabilization [BP] |
| CG_hsf1_promoter_p_PM_12_2_5 |
 |
 |
3 |
0.75 |
7.79E-05 |
FGFR4,
BDKRB1 |
alveolar secondary septum development [BP],
bradykinin receptor activity [MF] |
| CG_hsf1_promoter_p_PM_16_19_2 |
 |
 |
2 |
0.5 |
1.14E-04 |
GCAT |
glycine C-acetyltransferase activity [MF],
L-threonine catabolic process to glycine [BP] |
| CG_hsf1_promoter_p_PM_14_3_1 |
 |
 |
1 |
0.25 |
7.76E-04 |
ZNF205 |
positive regulation of hydrogen peroxide biosynthetic process [BP],
positive regulation of mitochondrial outer membrane permeabilization [BP] |
| CG_hsf1_promoter_p_PM_12_29_3 |
 |
 |
2 |
0.5 |
7.90E-05 |
B3GALT6 |
Golgi medial cisterna [CC],
galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF] |
| CG_hsf1_promoter_p_PM_12_31_2 |
 |
 |
1 |
0.25 |
2.26E-04 |
L3MBTL1,
TSC2,
CACNA1H |
SAM domain binding [MF],
caveola [CC] |
| CG_hsf1_promoter_p_PM_16_4_1 |
 |
 |
1 |
0.25 |
4.51E-05 |
IGHMBP2 |
ATP-dependent 5'-3' DNA helicase activity [MF],
ATP-dependent 5'-3' RNA helicase activity [MF] |
| CG_hsf1_promoter_p_PM_16_13_1 |
 |
 |
1 |
0.25 |
7.45E-04 |
PCDHA11,
PCDHA13,
PCDHA6,
PCDHA4,
PCDHA10 |
homophilic cell adhesion [BP],
nervous system development [BP],
integral to plasma membrane [CC],
calcium ion binding [MF],
cell adhesion [BP] |
| CG_hsf1_promoter_p_PM_12_33_1 |
 |
 |
2 |
0.5 |
1.47E-05 |
NEIL1,
SMPDL3B |
negative regulation of nuclease activity [BP],
hydrolase activity, acting on glycosyl bonds [MF] |
| CG_hsf1_promoter_p_PM_16_11_1 |
 |
 |
1 |
0.25 |
7.30E-05 |
RAD51,
MAP3K10 |
JUN kinase kinase kinase activity [MF],
DNA recombinase assembly [BP],
activation of JNKK activity [BP],
positive regulation of DNA ligation [BP] |
| CG_hsf1_promoter_p_PM_14_18_2 |
 |
 |
1 |
0.25 |
5.85E-04 |
PCDHA7,
PCDHA10,
PCDHA11,
PCDHA12,
PCDHA13,
PCDHA6 |
integral to membrane [CC],
plasma membrane [CC],
cell adhesion [BP],
homophilic cell adhesion [BP],
calcium ion binding [MF],
integral to plasma membrane [CC] |
| CG_hsf1_promoter_p_PM_12_17_3 |
 |
 |
1 |
0.25 |
3.31E-05 |
SCN1B,
MTO1,
KLHL41 |
mitochondrial tRNA wobble uridine modification [BP],
regulation of lateral pseudopodium assembly [BP],
voltage-gated sodium channel activity involved in regulation of Purkinje myocyte action potential [MF],
membrane depolarization involved in regulation of Purkinje myocyte cell action potential [BP] |
| CG_hsf1_promoter_p_PM_12_16_3 |
 |
 |
3 |
0.75 |
1.70E-04 |
MAU2 |
SMC loading complex [CC] |
| CG_hsf1_promoter_p_PM_12_20_2 |
 |
 |
2 |
0.5 |
1.98E-04 |
PNPLA2,
SLC5A10,
GPR123,
PCDHGB5,
PCDHGB4,
PCDHGA6,
PCDHGA12 |
homophilic cell adhesion [BP],
plasma membrane [CC],
calcium ion binding [MF],
integral to membrane [CC] |
| CG_hsf1_promoter_p_PM_16_9_1 |
 |
 |
2 |
0.5 |
6.52E-05 |
CENPA,
TAOK1 |
mitotic prometaphase [BP],
protein localization to chromosome, centromeric region [BP],
condensed chromosome inner kinetochore [CC] |
| CG_hsf1_promoter_p_PM_16_7_4 |
 |
 |
1 |
0.25 |
5.29E-05 |
RAC3,
TPM4 |
filamentous actin [CC] |
| CG_hsf1_promoter_p_PM_12_32_4 |
 |
 |
1 |
0.25 |
2.38E-04 |
SLCO1B3,
HSD3B7,
NSG1 |
cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity [MF],
dopamine receptor binding [MF],
bile acid metabolic process [BP],
dopamine receptor signaling pathway [BP] |
| CG_hsf1_promoter_p_PM_12_3_3 |
 |
 |
1 |
0.25 |
5.09E-04 |
PCDHA6,
PCDHA7,
PCDHA4,
PCDHA12,
PCDHA13,
EBI3,
B3GALT6 |
interleukin-27 receptor binding [MF],
Golgi medial cisterna [CC],
cell adhesion [BP],
homophilic cell adhesion [BP],
calcium ion binding [MF],
galactosylxylosylprotein 3-beta-galactosyltransferase activity [MF] |
| CG_hsf1_promoter_p_PM_14_17_4 |
 |
 |
3 |
0.75 |
3.34E-05 |
HMBS |
peptidyl-pyrromethane cofactor linkage [BP] |
| CG_hsf1_promoter_p_PM_12_8_4 |
 |
 |
1 |
0.25 |
1.93E-04 |
PARK7,
TYRO3,
CNTN2 |
positive regulation of adenosine receptor signaling pathway [BP],
positive regulation of oxidative phosphorylation uncoupler activity [BP],
establishment of protein localization to juxtaparanode region of axon [BP],
forebrain cell migration [BP],
adult locomotory behavior [BP] |
| CG_hsf1_promoter_p_PM_12_14_3 |
 |
 |
2 |
0.5 |
6.11E-05 |
BCO2 |
carotenoid metabolic process [BP],
carotene catabolic process [BP],
carotene metabolic process [BP] |
| CG_hsf1_promoter_p_PM_16_12_2 |
 |
 |
1 |
0.25 |
2.16E-05 |
SLC11A1 |
divalent metal ion export [BP],
metal ion:hydrogen antiporter activity [MF],
L-arginine import [BP],
cellular cadmium ion homeostasis [BP],
nitrite transport [BP],
tertiary granule membrane [CC] |
| CG_hsf1_promoter_p_PM_16_1_9 |
 |
 |
2 |
0.5 |
3.39E-05 |
EVL,
KIF5A,
PSEN1,
CDC42,
CAV1,
ICOS |
T cell costimulation [BP],
positive regulation of metalloenzyme activity [BP],
ciliary rootlet [CC],
cytoskeleton [CC],
regulation of protein binding [BP] |
| CG_hsf1_promoter_p_PM_14_23_1 |
 |
 |
1 |
0.25 |
4.73E-06 |
AGXT |
glyoxylate catabolic process [BP],
oxalic acid secretion [BP],
L-alanine catabolic process [BP],
glycine biosynthetic process, by transamination of glyoxylate [BP],
serine-pyruvate transaminase activity [MF],
glyoxylate metabolic process [BP],
pyruvate biosynthetic process [BP],
L-cysteine catabolic process [BP],
alanine-glyoxylate transaminase activity [MF] |
| CG_hsf1_promoter_p_PM_16_8_2 |
 |
 |
1 |
0.25 |
2.32E-04 |
PCDHA5,
PCDHA9,
PCDHA10,
PCDHA11,
PCDHA12,
PCDHA13,
PCDHA4 |
integral to membrane [CC],
plasma membrane [CC],
cell adhesion [BP],
homophilic cell adhesion [BP],
calcium ion binding [MF],
integral to plasma membrane [CC] |